|
|
Post by peppy on May 9, 2022 10:31:29 GMT -5
I am just taking photos now, 2 hours of trade, half the normal volume. $SPX down 110.  |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on May 9, 2022 11:18:21 GMT -5
I am just taking photos now, 2 hours of trade, half the normal volume. $SPX down 110. MNKD holding up strong today. Annual Meeting is tomorrow. Don't forget upon approval MNKD can exercise their $60M OPTION which will strengthen their BS. I heard on CNBC this morning a Good Balance Sheet with CASH is KING. MNKD checks those boxes. |
|
|
|
Post by porkini on May 9, 2022 12:16:25 GMT -5
I am just taking photos now, 2 hours of trade, half the normal volume. $SPX down 110. MNKD holding up strong today. Annual Meeting is tomorrow. Don't forget upon approval MNKD can exercise their $60M OPTION which will strengthen their BS. I heard on CNBC this morning a Good Balance Sheet with CASH is KING. MNKD checks those boxes. Thank you for clarifying that, at first glance I thought something different...  |
|
|
|
Post by dh4mizzou on May 9, 2022 14:36:55 GMT -5
Well so much for retiring in 3 years. :-(
|
|
|
|
Post by sayhey24 on May 9, 2022 14:57:26 GMT -5
Well so much for retiring in 3 years. :-( You will be in good shape. Lets hope the market finds a bottom before the FDA approval is announced. |
|
|
|
Post by peppy on May 9, 2022 15:15:04 GMT -5
MNKD Nasdaq real time volume, 4,987,781 shares. MNKD Nasdaq summary volume, 6,083,847 Avg. Volume 3,163,560 2.77. -0.18 (-6.1017%) As of 04:00PM EDT. Market open. Daily charts.     |
|
|
|
Post by rickf on May 9, 2022 16:40:30 GMT -5
Well so much for retiring in 3 years. :-( You will be in good shape. Lets hope the market finds a bottom before the FDA approval is announced. Sure hope your right - I have postponed my retirement for about 5 years now - still waiting until this pig fly's! |
|
|
|
Post by sayhey24 on May 9, 2022 16:59:17 GMT -5
You will be in good shape. Lets hope the market finds a bottom before the FDA approval is announced. Sure hope your right - I have postponed my retirement for about 5 years now - still waiting until this pig fly's! I could be wrong but I have a feeling Tyvaso DPI will be approved soon. That should start the dominos to fall. We are sitting on the greatest advance in diabetes care in over 100 years. Its a near cure for some T2 diabetics. Nothing else can do what afrezza does. Mike has all the pieces to make it happen except it being endorsed in a T2 SoC. Once he gets that, Boom. In the mean time Martine can sell some Tyvaso DPI and Receptor Life can work to get their first approved product. |
|
|
|
Post by cretin11 on May 9, 2022 18:00:04 GMT -5
Sure hope your right - I have postponed my retirement for about 5 years now - still waiting until this pig fly's! I could be wrong but I have a feeling Tyvaso DPI will be approved soon. That should start the dominos to fall. We are sitting on the greatest advance in diabetes care in over 100 years. Its a near cure for some T2 diabetics. Nothing else can do what afrezza does. Mike has all the pieces to make it happen except it being endorsed in a T2 SoC. Once he gets that, Boom. In the mean time Martine can sell some Tyvaso DPI and Receptor Life can work to get their first approved product. Is MC actively working to get Afrezza endorsed in a T2 SOC? |
|
|
|
Post by peppy on May 9, 2022 18:08:17 GMT -5
I could be wrong but I have a feeling Tyvaso DPI will be approved soon. That should start the dominos to fall. We are sitting on the greatest advance in diabetes care in over 100 years. Its a near cure for some T2 diabetics. Nothing else can do what afrezza does. Mike has all the pieces to make it happen except it being endorsed in a T2 SoC. Once he gets that, Boom. In the mean time Martine can sell some Tyvaso DPI and Receptor Life can work to get their first approved product. Inappropriate post here by me. The powers that be seem to be working on healthcare changes. So here is a thought. If we can make phosphodiesterase-5 (PDE5) inhibitor illegal, trept would be an in demand black market item. Everybody would have pulmonary hypertension and sales would sky rocket.  |
|
|
|
Post by sayhey24 on May 9, 2022 19:43:22 GMT -5
I could be wrong but I have a feeling Tyvaso DPI will be approved soon. That should start the dominos to fall. We are sitting on the greatest advance in diabetes care in over 100 years. Its a near cure for some T2 diabetics. Nothing else can do what afrezza does. Mike has all the pieces to make it happen except it being endorsed in a T2 SoC. Once he gets that, Boom. In the mean time Martine can sell some Tyvaso DPI and Receptor Life can work to get their first approved product. Is MC actively working to get Afrezza endorsed in a T2 SOC? Sometimes people need help thinking outside the box. Dave Kendall saw the ADA as being in charge of "the SoC". I say, hey who says. At the time I assumed Dave was correct. Hey, Dave was a thought leader. He was the chief scientific and medical officer for the ADA. Up until very recently I think Mike also assumed Dave was correct and the ADA controlled "THE SoC". I am hoping he now realizes each organization has their own SoC and its his job to work with more than the ADA. He does not need afrezza in the ADA SoC, he needs afrezza in "a SoC". The AACE would work. He will be at the AACE conference in a few days - events.jspargo.com/aace22/Public/eventmap.aspx?shmode=E&shExhList=1&ID=95554&sortMenu=102000I am hoping he does more than get a good feeling after talking with a lot of thought leaders as he did at the ATTD. This is a great opportunity to start framing the AACE T2 SoC with CGMs and afrezza front and center. Whats the AACE got to lose? They are already playing second seat to the ADA. Maybe a few "Seeing is Believing" live demos could shake things up. |
|
|
|
Post by cretin11 on May 9, 2022 20:48:21 GMT -5
Interesting strategy. I worry MC is not a “rock the boat” kinda guy. Would love for the opposite to prove true.
|
|
|
|
Post by prcgorman2 on May 9, 2022 21:10:02 GMT -5
I have some famiiarity with industry associations and standards development organizations (and regulatory authorities) and do agree there can blurring of lines, and for sure dominant members of an industry will sometimes influence standards in a way that match their product and marketing directions. This is capitalism.
I find sayhey’s arguments persuasive in terms of establishing an inhaled insulin standard of care, but I do not assume that this is the missing piece in the Mannkind marketing strategy. I also agree with sayhey that “Seeing is Believing” is a smart move to bring attention to Afrezza’s ultra-rapid action, and even moreso if it can highlight Afrezza’s SAFETY as compared to other insulins.
I continue to believe that endocrinologists are the bottle-neck in that they want data from studies and that general practioners follow the lead of the endos.
And to get us back on topic. How about that volume today, huh? More than 6 millions shares. Makes me wish I’d waited to add. But I think I’m done until we find out what the FDA is going to do with Treprostinil DPI.
|
|
|
|
Post by peppy on May 10, 2022 9:01:45 GMT -5
What the heck is going on with volume?
@ 1/2 hour
real time,, 644,096
summary, 711,310
Avg. Volume 3,210,835
2.9750 +0.205. (+7.4007%)
As of 10:01AM EDT. Market open.
|
|
|
|
Post by minnlearner on May 10, 2022 11:14:30 GMT -5
Perfect!
|
|
